Caxton Corp 13F annual report

Caxton Corp is an investment fund managing more than $17.6 billion ran by Heath Weisberg. There are currently 11 companies in Mr. Weisberg’s portfolio. The largest investments include Xeris Biopharma Inc and Rezolute Inc, together worth $14.7 billion.

$17.6 billion Assets Under Management (AUM)

As of 8th May 2024, Caxton Corp’s top holding is 5,113,348 shares of Xeris Biopharma Inc currently worth over $11.3 billion and making up 64.4% of the portfolio value. Relative to the number of outstanding shares of Xeris Biopharma Inc, Caxton Corp owns more than approximately 0.1% of the company. In addition, the fund holds 1,318,967 shares of Rezolute Inc worth $3.36 billion. The third-largest holding is Spdr S&p 500 Etf Tr worth $971 million and the next is Berkshire Hathaway worth $428 million, with 1,019 shares owned.

Currently, Caxton Corp's portfolio is worth at least $17.6 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Caxton Corp

The Caxton Corp office and employees reside in Princeton, New Jersey. According to the last 13-F report filed with the SEC, Heath Weisberg serves as the Chief Compliance Officer at Caxton Corp.

Recent trades

In the most recent 13F filing, Caxton Corp revealed that it had opened a new position in Spdr S&p 500 Etf Tr and bought 1,856 shares worth $971 million.

On the other hand, there are companies that Caxton Corp is getting rid of from its portfolio. Caxton Corp closed its position in Savara Inc on 15th May 2024. It sold the previously owned 4,980,804 shares for $16 billion. Heath Weisberg also disclosed a decreased stake in Xeris Biopharma Inc by approximately 0.1%. This leaves the value of the investment at $11.3 billion and 5,113,348 shares.

One of the smallest hedge funds

The two most similar investment funds to Caxton Corp are Ares Management and Jarislowsky, Fraser Ltd. They manage $17.5 billion and $17.4 billion respectively.

Heath Weisberg investment strategy

Caxton Corp’s portfolio is diversified across 3 sectors. Currently, their heaviest sector is Health Care — making up 66.1% of the total portfolio value. The fund focuses on investments in the United States as 27.3% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 9% of the total holdings value. On the other hand, small-cap stocks make up only 9.1% of the portfolio. The average market cap of the portfolio companies is close to $225 billion.

The complete list of Caxton Corp trades based on 13F SEC filings

These positions were updated on May 15th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security	Shares Owned	Value	Allocation
Savara Inc	Closed 4,980,804	$16,026,005,000
Xeris Biopharma Holdings Inc	9.37% 5,113,348	$11,300,499,000	64.38%
Rezolute Inc	No change 1,318,967	$3,363,366,000	19.16%
Molecular Templates Inc	Closed 2,052,991	$985,436,000
Spdr S&p 500 Etf Tr	Opened 1,856	$970,988,000	5.53%
Berkshire Hathaway Inc.	Opened 1,019	$428,308,000	2.44%
Kyverna Therapeutics Inc	Opened 15,846	$393,614,000	2.24%
Molecular Templates Inc	Opened 136,866	$306,580,000	1.75%
Mind Medicine Mindmed Inc	Opened 29,065	$273,207,000	1.56%
Abivax Sa	Opened 15,808	$226,055,000	1.29%
Lexeo Therapeutics Inc	Opened 10,319	$161,796,000	0.92%
Compass Therapeutics Inc	0.00% 43,465	$86,062,000	0.49%
Allakos Inc	Closed 17,733	$77,318,000
Adicet Bio Inc	Opened 17,488	$41,096,000	0.23%
Elevation Oncology Inc	Closed 21,725	$33,022,000
No transactions found
Showing first 500 out of 15 holdings